JPH0363071A - Drug administration appliance assisted by ultrasonic wave - Google Patents
Drug administration appliance assisted by ultrasonic waveInfo
- Publication number
- JPH0363071A JPH0363071A JP1199865A JP19986589A JPH0363071A JP H0363071 A JPH0363071 A JP H0363071A JP 1199865 A JP1199865 A JP 1199865A JP 19986589 A JP19986589 A JP 19986589A JP H0363071 A JPH0363071 A JP H0363071A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- oscillation element
- ultrasonic oscillation
- ultrasonic
- paper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001647 drug administration Methods 0.000 title claims description 21
- 239000003814 drug Substances 0.000 claims abstract description 78
- 229940079593 drug Drugs 0.000 claims abstract description 78
- 230000010355 oscillation Effects 0.000 claims abstract description 28
- 239000002775 capsule Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 12
- 230000004308 accommodation Effects 0.000 claims 1
- 239000000853 adhesive Substances 0.000 abstract description 9
- 230000001070 adhesive effect Effects 0.000 abstract description 9
- 230000001681 protective effect Effects 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 10
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000002547 new drug Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000002313 adhesive film Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 1
- 229910002113 barium titanate Inorganic materials 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- NKZSPGSOXYXWQA-UHFFFAOYSA-N dioxido(oxo)titanium;lead(2+) Chemical compound [Pb+2].[O-][Ti]([O-])=O NKZSPGSOXYXWQA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229910052845 zircon Inorganic materials 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、超音波を利用して薬物を皮膚、各種粘膜等よ
り人体に投与する投与具の使用薬物部が分離でき、薬物
の補充、切換等が容易に行なえる超音波による薬物投与
具に関する。[Detailed Description of the Invention] [Industrial Field of Application] The present invention is capable of separating the drug portion of a drug administration device for administering drugs to the human body through the skin, various mucous membranes, etc. using ultrasound, and is capable of replenishing and replenishing drugs. This invention relates to an ultrasonic drug administration device that can be easily switched.
人の病気の治療、予防等に外部より薬物を投与する方法
としては、注射剤9錠剤、カプセル剤。Methods for externally administering drugs for the treatment and prevention of human diseases include injections, 9 tablets, and capsules.
座剤等の経口、非経口的に投与する方法、並びに軟膏剤
、貼付剤等の経皮吸収により投与する方法が従来使用さ
れている。このうち、経皮吸収による薬物投与方法は皮
膚からの薬物の吸収が極めて微量であるため、直接的外
用薬以外は殆ど経口又は注射剤等が用いられてきた。Oral or parenteral administration methods such as suppositories, and transdermal administration methods such as ointments and patches have been conventionally used. Among these, in the drug administration method by transdermal absorption, since the amount of drug absorbed through the skin is extremely small, oral administration or injections have been mostly used except for direct topical drugs.
しかるに、経口、注射剤等においては、薬物投与後、そ
の薬物濃度が一般に速やかにピークに達し、その後時間
と共に減少し安定に一定な血中濃度を保つことは困難で
あった。更に、最も一般的に使用されている経口投与剤
でも胃腸障害、肝機能障害等を起こす恐れがあり、また
腸管からの薬物の吸収後、初回肝通過時の薬物の不活性
化等のため、薬物としての使用可能な条件を揃えたもの
は極く限られている。また、注射剤の場合は針の使用や
異物を直接体内に注入することにより免疫反応を起こす
等の種々の難点があり、ショック等の危険性もある。−
度注射によって体内に注入された薬物の回収は不可能で
ある。However, in the case of oral or injectable drugs, the drug concentration generally reaches a peak quickly after drug administration, and then decreases over time, making it difficult to maintain a stable blood concentration. Furthermore, even the most commonly used orally administered drugs may cause gastrointestinal disorders, liver dysfunction, etc., and the drug is inactivated during the first passage through the liver after absorption from the intestinal tract. There are only a limited number of substances that meet the conditions for use as drugs. Furthermore, in the case of injections, there are various disadvantages such as the use of needles and the direct injection of foreign substances into the body, which causes an immune reaction, and there is also the risk of shock. −
It is impossible to recover drugs that have been injected into the body by multiple injections.
そこで、本発明者はこれらの難点のない軟膏剤。Therefore, the present inventor has developed an ointment that does not have these drawbacks.
貼付剤等の経皮膚投与剤の皮膚からの吸収が極めて重量
であることが原因である、薬物の皮膚の角質層或いはケ
ラチン層を通過することの困難性を解決するため、先に
皮膚に外傷を与えない程度の物理的エネルギーを利用し
て薬物の皮膚内への侵入を可能にし、薬物が良好に皮膚
の角質層、ケラチン層を通過し、薬物の血中濃度を充分
に維持させる方法を見出し、超音波発振素子に近接して
薬物層を設けた経皮投与具を発明し、特開昭63−13
5179号公報で開示した。In order to solve the difficulty of drugs passing through the stratum corneum or keratin layer of the skin, which is caused by the extremely heavy absorption of transdermal drugs such as patches, we first apply trauma to the skin. We developed a method that allows drugs to penetrate into the skin using physical energy that does not cause damage, allows drugs to pass through the stratum corneum and keratin layers of the skin, and maintains sufficient blood concentration of drugs. Heading: Invention of a transdermal administration device in which a drug layer is provided close to an ultrasonic oscillation element;
It was disclosed in Publication No. 5179.
前述のような薬物の経皮素通過性を良好にした超音波発
振素子と薬物層を一つの投与真向に備えた経皮投与具に
おいては、新たに薬物を追加して同投与を継続する場合
、連続して他の薬物に切り換えて投与する場合等におい
て、薬物層を取り替える事情が生じた場合は、新たな経
皮投与具を常に用意しておかなければならず、また種々
の薬物層を備えた経皮投与具を多数常備する等の治療上
煩雑な点が多々あった。In the above-mentioned transdermal administration device, which is equipped with an ultrasonic oscillation element that improves transdermal permeability of the drug and a drug layer directly in front of one administration, a new drug is added and the same administration is continued. If the need arises to replace the drug layer, such as when switching to another drug and administering it continuously, a new transdermal administration device must always be prepared, and a new drug layer must be prepared at all times. There were many complications in terms of treatment, such as having to keep a large number of transdermal administration devices equipped with
本発明は超音波による薬物投与具において、前述の欠点
を除き治療上において同一の薬物を追加して連続投与し
たり、他の薬物に切換え投与する場合において、薬物部
のみを切り換えることができる、所謂、使い捨て式超音
波による薬物投与具を提供するものである。The present invention provides an ultrasonic drug administration device that, except for the above-mentioned drawbacks, allows only the drug part to be switched when the same drug is added and continuously administered for treatment or when switched to another drug. The present invention provides a so-called disposable ultrasonic drug administration device.
本発明は、超音波発振素子の下面に密着して薬物を塗布
した紙、布状物又は薬物を収容した袋状物を着脱可能に
装着した投与具、並びに棒状又は薬物収容カプセル収容
空間を先端に有する超音波発振機子の先端にこれと密着
して薬物を収容したカプセルを着脱可能に装着した超音
波による薬物投与具である。The present invention provides an administration device in which a drug-coated paper, cloth-like material, or a bag-like material containing a drug is attached to the lower surface of an ultrasonic oscillation element in a removable manner, and a rod-shaped or drug-containing capsule housing space is provided at the tip. This is an ultrasonic drug administration device in which a capsule containing a drug is removably attached to the tip of an ultrasonic oscillator in close contact with the tip.
本発明はこのような構造にすることにより、同一薬物の
追加、異なる薬物の切り換え時において、薬物を塗布し
た紙、布状物、薬物を収容した袋状物又はカプセル等の
みを投与具の先端に貼付、嵌合、挿入することにより、
簡単な操作で容易に切り換えをすることができると共に
、常備するのは薬物部のみで投与具は常に同一のものを
使用し得る利点がある。By adopting such a structure, the present invention allows only paper, cloth-like material coated with the drug, bag-like material containing the drug, capsule, etc., to be placed at the tip of the administration tool when adding the same drug or switching between different drugs. By pasting, fitting, and inserting the
It has the advantage that switching can be done easily with a simple operation, and that the same administration tool can always be used since only the drug part is kept at hand.
本発明の超音波による薬物投与具としては、超音波発振
機の種類、電源の種類を選択することにより、静置型、
携帯型、常用型、貼付型等の種々の形式のものとするこ
とができる。The ultrasonic drug administration device of the present invention can be of a stationary type, by selecting the type of ultrasonic oscillator and the type of power source.
It can be of various types such as portable type, regular use type, stick-on type, etc.
静置型は例えば、第1図に示すように、一般の交流電源
に接続した超音波発振機1と筒状容器の底部に設けた先
端が棒状に成形した超音波発振素子2を導線で接続して
納入し、その容器の先端に挿入、離脱可能に円筒状で、
且つその上部に超音波発振素子の棒状部が挿入できる孔
を有する薬物が収容された薬物カプセル3を装着した投
与具である。この型において、超音波発振素子2の形状
を第2図に示すように、先端を薬物収容カプセルの形状
に適合した空間を有し、この先端に薬物カプセルを嵌合
する形状にしてもよい。For example, as shown in Fig. 1, the stationary type has an ultrasonic oscillator 1 connected to a general AC power source and an ultrasonic oscillator element 2 with a rod-shaped tip provided at the bottom of a cylindrical container, connected by a conductor. It is cylindrical and can be inserted and removed from the tip of the container.
This administration device is equipped with a drug capsule 3 containing a drug, which has a hole into which a rod-shaped part of an ultrasonic oscillation element can be inserted. In this type, the shape of the ultrasonic oscillation element 2 may be such that the tip thereof has a space adapted to the shape of the drug-accommodating capsule, and the drug capsule is fitted into the tip, as shown in FIG.
この型においては、電源として一般の電源を使用できる
から持続的に高エネルギーを供給することができる。ま
た、超音波発振素子も普通に用いられるチタン酸バリウ
ム、ジルコン・チタン酸鉛等のセラミック、金属及び高
分子軟質フィルム等を用いることができる。In this type, a general power source can be used as the power source, so high energy can be continuously supplied. Further, the ultrasonic oscillation element can be made of commonly used ceramics such as barium titanate, zircon/lead titanate, metals, polymer soft films, and the like.
この据置型は病院、家庭等で短時間皮膚に当てて使用す
る場合に好適である。This stationary type is suitable for use in hospitals, homes, etc. by applying it to the skin for a short period of time.
そして、薬物を新たに追加又は他の薬物に切り換える場
合は、本投与具の先端の薬物カプセルを同投与具の先端
部において取り替えることによって簡単な操作で行うこ
とができる。When adding a new drug or switching to another drug, this can be done with a simple operation by replacing the drug capsule at the tip of the administration device at the tip of the same administration device.
携帯型は例えば第3図に示すように、筒状容器に電池4
と超音波発振機1及び超音波発振素子2を導線で接続し
て納入し、その先端に薬物カプセル3を着脱可能に装着
した型のものである。なお、第3図においては超音波発
振素子2の形状を棒状のもので示したが、第2図の薬物
収容カプセルを嵌合する形状のものでもよい。For example, as shown in Figure 3, the portable type has four batteries in a cylindrical container.
In this type, an ultrasonic oscillator 1 and an ultrasonic oscillating element 2 are connected to each other by a conductive wire, and a drug capsule 3 is detachably attached to the tip of the ultrasonic oscillator 1. Although the shape of the ultrasonic oscillation element 2 is shown as a rod in FIG. 3, it may be shaped to fit into the drug-accommodating capsule shown in FIG. 2.
この携帯型は比較的小型で、しかも電源、超音波発振機
を単一の容器に内蔵しであるから、常時携帯して必要な
時に本投与具を取り出し、患部に当接することによって
薬物を投与することができる。また、薬物の追加投与、
切り換え投与をする場合は、薬物カプセルの切り換えの
みで行えるから極めて簡便である。This portable type is relatively small and has a power source and an ultrasonic oscillator built into a single container, so it can be carried around at all times, and when needed, it can be taken out and administered by touching it to the affected area. can do. Also, additional administration of drugs,
Switching administration is extremely simple because it can be done simply by switching drug capsules.
常用型は、例えば第4図に示すように、偏平型容器に小
型電池4と小型超音波発振機、例えばIC発振機1及び
超音波発振素子2を導線で接続して納入し、超音波発振
素子2の下面に薬物層3を備えた型のものである。For example, as shown in Fig. 4, the regular type is delivered in a flat container with a small battery 4 and a small ultrasonic oscillator, such as an IC oscillator 1 and an ultrasonic oscillator 2, connected with a conductor wire, and then the ultrasonic oscillation is started. It is of the type in which a drug layer 3 is provided on the lower surface of the element 2.
この型のものは容器の両側にバンドを付け、常時本容器
の薬物層を患部に当接しておくと、常時薬物を投与する
必要のある患部に対し適している。This type of container has bands attached to both sides of the container to keep the drug layer of the container in contact with the affected area at all times, making it suitable for affected areas where it is necessary to constantly administer drugs.
貼付型は例えば、第5図に示すように、外部発振機に接
続する端子9を有する超音波発振素子2の下面に超音波
発振素子と接着する接着紙5、薬物透過貼付膜6にクリ
ーム状、ゲル状の薬物層7を塗布した薬物層を積層し、
最下面である皮膚に当接する面に保護紙8を貼付した型
投与具である。For example, as shown in FIG. 5, the adhesive type has an adhesive paper 5 attached to the ultrasonic oscillation element on the lower surface of the ultrasonic oscillation element 2 having a terminal 9 connected to an external oscillator, and a cream-like material on the drug-permeable adhesive membrane 6. , laminating drug layers coated with a gel-like drug layer 7;
This is a type of administration device with a protective paper 8 pasted on the lowermost surface that comes into contact with the skin.
使用の際は、最下面の保護紙8を剥離し、貼付膜6を患
部に貼付し、端子9を外部発振機に接続し投与を行う。When in use, the lowermost protective paper 8 is peeled off, the adhesive film 6 is applied to the affected area, and the terminal 9 is connected to an external oscillator for administration.
薬物の取り替え、切り換えは超音波発振素子2に接着さ
れている接着紙5の部分で剥離し、新たな薬物層を含む
積層体を接着して使用する。To replace or switch the drug, the part of the adhesive paper 5 bonded to the ultrasonic oscillation element 2 is peeled off, and a laminate containing a new drug layer is bonded and used.
なお、薬物が液体の場合は薬物透過貼付膜6に薬物液を
収容した袋状物を貼付して使用する。In addition, when the drug is a liquid, a bag-like material containing the drug liquid is attached to the drug-permeable adhesive membrane 6 for use.
超音波発振素子2として、圧電セラミックからなる電わ
い振動子、フェライトを用いた磁わい振動子等があり、
また、セラミックでも、柔らかいフィルムタイプのもの
でもよい。As the ultrasonic oscillation element 2, there are electric strain vibrators made of piezoelectric ceramics, magnetic strain vibrators using ferrite, etc.
Further, it may be a ceramic or a soft film type.
本発明の投与具は、その形状、材質、薬物を適宜選択す
ることによって、皮膚のみならず、口内。The administration device of the present invention can be used not only on the skin but also in the mouth by appropriately selecting its shape, material, and drug.
消化管等の各種粘膜を透して薬物を投与することができ
る。Drugs can be administered through various mucous membranes such as the gastrointestinal tract.
本発明に使用する薬物は、従来の軟膏剤、貼付剤等の経
皮吸収に使用されている薬物、例えばスコポラミン、ニ
トログリセリン、インドメタシン。The drugs used in the present invention include drugs conventionally used for percutaneous absorption in ointments, patches, etc., such as scopolamine, nitroglycerin, and indomethacin.
ケトプロフェン、塩化カルプロニウム等、従来の軟膏剤
、貼付剤等で皮膚吸収が困難であった薬物、例えば高分
子物であるインスリン、各種ホルモン剤、抗生物質、制
癌剤、抗高血圧剤等の持続投与にも使用できる。For continuous administration of drugs such as ketoprofen and carpronium chloride, which are difficult to absorb through the skin using conventional ointments and patches, such as insulin, which is a polymer, various hormones, antibiotics, anticancer drugs, antihypertensive drugs, etc. Can be used.
また、血管確保の困難な重症緊急患者に対する昇圧剤投
与にも適するものである。It is also suitable for administering vasopressors to severe emergency patients in whom it is difficult to secure blood vessels.
例1
第1図に示すように、先端に薬物収容カプセ、し3が挿
入され得る開口部を有する合成樹脂製の円筒型ホルダー
中に、ホルダー内面とスポンジ状緩衝材10により超音
波発振素子2を配設し、ホルダー上面に該発振素子2と
導線により接続されている端子9を設け、このホルダー
の先端開口部に上面が開放された薬物収容カプセル3を
着脱可能に挿入し、該薬物収容カプセル中に該発振素子
2の先端棒状部を差し込んだ静置型薬物投与具である。Example 1 As shown in FIG. 1, an ultrasonic oscillation element 2 is placed between the inner surface of the holder and a sponge-like cushioning material 10 in a cylindrical holder made of synthetic resin having an opening at the tip into which a drug-containing capsule 3 can be inserted. A terminal 9 connected to the oscillation element 2 by a conductive wire is provided on the top surface of the holder, and a drug-containing capsule 3 with an open top surface is removably inserted into the opening at the tip of the holder. This is a stationary drug administration device in which the rod-shaped tip of the oscillation element 2 is inserted into a capsule.
この投与具の端子9は一般の電源に接続される可変型超
音波発振機1に接続して使用される。The terminal 9 of this administration device is used by being connected to a variable ultrasonic oscillator 1 connected to a general power source.
例2
第5図に示すように、端子9を備えた円板状セラミック
発振素子2の下面に、最上層に超音波発振素子2と接着
する接着紙5、クリーム状の薬物層7、薬物透過製貼付
膜6を積層した薬物塗布紙状物を発振素子2に貼付し、
保存時には薬物透過性貼付膜6の下面に保護紙8を貼っ
た貼付型薬物投与具である。この投与具の端子9は一駿
電源に接続されている可変型超音波発振機に接続して使
用される。また、小型携帯型超音波発振機に接続して使
用することもできる。Example 2 As shown in FIG. 5, on the bottom surface of a disc-shaped ceramic oscillation element 2 equipped with a terminal 9, an adhesive paper 5 that adheres to the ultrasonic oscillation element 2 as the top layer, a cream-like drug layer 7, and a drug permeable A drug-coated paper-like material laminated with a manufactured adhesive film 6 is pasted on the oscillation element 2,
It is a pasted drug administration device in which a protective paper 8 is pasted on the lower surface of the drug-permeable pasted membrane 6 during storage. The terminal 9 of this administration device is used by being connected to a variable ultrasonic oscillator connected to a power source. It can also be used by connecting to a small portable ultrasonic oscillator.
本発明は上述の通り、超音波振動により薬物を皮膚を始
め各種の粘膜1口内、消化管等の臓器の外部からそれら
の組織を浸透し吸収させ、その薬物の薬物の放出制御を
超音波出力の変動によって行うことができる極めて有用
な投与具で、更に薬物の収容部を随時取り替えることが
でき、その取り替えも極めて簡便にすることができる有
用な薬物投与具である。As described above, the present invention uses ultrasonic vibrations to penetrate and absorb drugs from the skin, various mucous membranes, the inside of the mouth, and external organs such as the gastrointestinal tract, and controls the release of the drug by outputting ultrasonic waves. This is an extremely useful drug administration device that can be used to perform drug administration by changing the amount of the drug.Furthermore, it is a very useful drug administration device that allows the drug storage portion to be replaced at any time and can be replaced extremely easily.
第1図は本発明の静置型薬物投与具の棒状超音波発振素
子を使用したものの断面図である。
第2図は第1図における静置型薬物投与具の超音波発振
素子の先端を薬物収容カプセルと適合する形状に成形し
た超音波発振素子を使用したものの断面図である。
第3図は本発明の携帯型薬物投与具の断面図である。
第4図は本発明の常用型薬物投与具の断面図である。
第5図は本発明の貼付型薬物投与具の断面図である。
1:超音波発振機 2:超音波発振素子3:薬物収
容カプセル 4:電池
5:接着紙
6:薬物透過性貼付膜 7:薬物層
8:保護紙 9:端子
10: 緩衝材FIG. 1 is a sectional view of a stationary drug administration device of the present invention using a rod-shaped ultrasonic oscillation element. FIG. 2 is a cross-sectional view of the stationary drug administration device shown in FIG. 1, which uses an ultrasonic oscillation element in which the tip of the ultrasonic oscillation element is molded into a shape compatible with a drug containing capsule. FIG. 3 is a cross-sectional view of the portable drug administration device of the present invention. FIG. 4 is a cross-sectional view of the conventional drug administration device of the present invention. FIG. 5 is a sectional view of the adhesive-type drug administration device of the present invention. 1: Ultrasonic oscillator 2: Ultrasonic oscillator 3: Drug-containing capsule 4: Battery 5: Adhesive paper 6: Drug-permeable pasting membrane 7: Drug layer 8: Protective paper 9: Terminal 10: Cushioning material
Claims (1)
、布状物又は薬物を収容した袋状物を着脱可能に装着し
てなることを特徴とする超音波による薬物投与具。 2、棒状又は薬物収容カプセル収容空間を先端に有する
超音波発振素子の先端に、これと密着して薬物を収容し
たカプセルを着脱可能に装着してなることを特徴とする
超音波による薬物投与具。[Scope of Claims] 1. Ultrasonic waves characterized in that a paper, cloth-like material coated with a drug, or a bag-like material containing a drug is removably attached to the lower surface of an ultrasonic oscillation element. Drug administration device by. 2. An ultrasonic drug administration device comprising a rod-shaped ultrasonic oscillation element having a drug-containing capsule accommodation space at its tip, and a capsule containing a drug in close contact with the ultrasonic oscillation element detachably attached thereto. .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1199865A JPH074428B2 (en) | 1989-07-31 | 1989-07-31 | Ultrasonic drug administration device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1199865A JPH074428B2 (en) | 1989-07-31 | 1989-07-31 | Ultrasonic drug administration device |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0363071A true JPH0363071A (en) | 1991-03-19 |
JPH074428B2 JPH074428B2 (en) | 1995-01-25 |
Family
ID=16414930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1199865A Expired - Fee Related JPH074428B2 (en) | 1989-07-31 | 1989-07-31 | Ultrasonic drug administration device |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH074428B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009062421A1 (en) * | 2007-11-13 | 2009-05-22 | Chongqingshi Shengli Medical Equipment Co., Ltd | Ultrasonic medicine paste |
US9050053B2 (en) | 2013-02-15 | 2015-06-09 | Naimco, Inc. | Ultrasound device with cavity for conductive medium |
US9480863B2 (en) | 2009-12-31 | 2016-11-01 | ZetrOZ Systems, LLC | Ultrasound coupling device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52115591A (en) * | 1976-02-09 | 1977-09-28 | Fahim Mostafa S | Method of local medication |
JPS6099940U (en) * | 1983-12-13 | 1985-07-08 | 阿部 俊三 | athlete's foot treatment device |
JPS63135179A (en) * | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
-
1989
- 1989-07-31 JP JP1199865A patent/JPH074428B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52115591A (en) * | 1976-02-09 | 1977-09-28 | Fahim Mostafa S | Method of local medication |
JPS6099940U (en) * | 1983-12-13 | 1985-07-08 | 阿部 俊三 | athlete's foot treatment device |
JPS63135179A (en) * | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009062421A1 (en) * | 2007-11-13 | 2009-05-22 | Chongqingshi Shengli Medical Equipment Co., Ltd | Ultrasonic medicine paste |
AU2008323454B2 (en) * | 2007-11-13 | 2013-11-14 | Chongqing Ronghai Engineering Research Center Of Ultrasonic Medicine Co., Ltd. | Ultrasonic medicine paste |
US9480863B2 (en) | 2009-12-31 | 2016-11-01 | ZetrOZ Systems, LLC | Ultrasound coupling device |
US9050053B2 (en) | 2013-02-15 | 2015-06-09 | Naimco, Inc. | Ultrasound device with cavity for conductive medium |
Also Published As
Publication number | Publication date |
---|---|
JPH074428B2 (en) | 1995-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0363913B2 (en) | ||
US6908448B2 (en) | Substance delivery device | |
US5415629A (en) | Programmable apparatus for the transdermal delivery of drugs and method | |
US7440798B2 (en) | Substance delivery system | |
US5667487A (en) | Ionosonic drug delivery apparatus | |
JP2538371B2 (en) | Medical device for transdermal or mucus administration of active substances | |
US20180325836A1 (en) | Ultrasonic transducers suitable for ultrasonic drug delivery via a system, which is portable and wearable by the patient | |
EP2213326B1 (en) | Ultrasonic medicine paste | |
JP2788307B2 (en) | Drug dosing device | |
WO2006016647A1 (en) | Transdermal drug administration apparatus with microneedle | |
US20050075599A1 (en) | Ultrasonically enhanced saline treatment for burn damaged skin | |
JPH0810340A (en) | Plaster structure for iontophoresis | |
JP2006149818A (en) | Percutaneous administration device | |
JP2005525147A (en) | Substance delivery device | |
JPH0363071A (en) | Drug administration appliance assisted by ultrasonic wave | |
JPH0530777Y2 (en) | ||
JP2003052840A (en) | Medicine pasting sheet with electrode | |
JPH02299668A (en) | Bioelectrode for skin treatment | |
JPH02224752A (en) | Skin breaking device for endermic medication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |